Accession | Disease | Description | Year | Source | RNA-Seq | Count | Biomarkers |
GSE13159 | Leukemia | Microarray Innovations in LEukemia (MILE) study: Stage 1 data | 2008 | Bone Marrow | N | 2096 | |
GSE13164 | Leukemia | Microarray Innovations in LEukemia (MILE) study: Stage 2 data | 2008 | Bone Marrow | N | 1152 | |
E-MTAB-4717 | Multiple Myeloma | Transcription profiling by array of human CD138 purified bone marrow plasma cells from patients with multiple myeloma | 2016 | Bone marrow | N | 630 | |
GSE118900 | Multiple Myeloma | Molecular Signatures of Multiple Myeloma Progression through Single Cell RNA-Seq | 2018 | Blood | Y | 597 | |
GSE2658 | Multiple Myeloma | Gene Expression Profiles of Multiple Myeloma | 2005 | Bone marrow | N | 559 | |
GSE4204 | Multiple Myeloma | Gene Expression Profiles of Multiple Myeloma Before Treatment | 2006 | Bone marrow | N | 538 | |
GSE6891 | Leukemia | Acute myeloid leukemia samples of samples =< 60yr | 2007 | Blood | N | 537 | |
GSE14468 | Leukemia | Gene expression profiling of CEBPA double and single mutant and CEBPA wild type AML. | 2009 | Blood | N | 526 | |
GSE37642 | Leukemia | Prognostic gene signature for AML | 2012 | Bone Marrow | N | 422 | |
GSE12417 | Leukemia | Prognostic gene signature for normal karyotype AML | 2012 | Bone Marrow | N | 405 | |
GSE106291 | Leukemia | A 29-Gene and Cytogenetic Score for the Prediction of Resistance to Induction Treatment in Acute Myeloid Leukemia | 2017 | Blood | Y | 250 | |
GSE46261 | Leukemia | Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia | 2013 | Blood | N | 229 | |
GSE13351 | Leukemia | Expression data from ALL samples for patients included in the Dutch Childhood Oncology Group | 2008 | Blood | N | 107 | |
GSE63270 | Leukemia | Expression profiles of normal hematopoietic stem and progenitor cells and acute myeloid leukemia sub-populations | 2014 | Bone Marrow | N | 104 | |
E-MTAB-4715 | Multiple Myeloma | Transcription profiling by array of human CD138 purified bone marrow plasma cells from relapsed multiple myeloma patients | 2016 | Bone marrow | N | 82 | |
GSE51723 | Leukemia | Therapy-induced PML nuclear body re-formation and p53 activation trigger acute promyelocytic leukaemia cure | 2013 | Blood | N | 72 | |
E-MTAB-5212 | Multiple Myeloma | Transcription profiling by array of human CD138 purified bone marrow plasma cells, CD27 memory B-cells, polyclonal plasmablastic cells and human myeloma cell lines | 2016 | Bone marrow | N | 58 | |
GSE77750 | Leukemia | Identification of genes that may predict response to azacitidine treatment. | 2016 | Bone Marrow | N | 42 | |
GSE77191 | Leukemia | Combination of multiomics approach and BCR-ABL based molecular testing | 2016 | Blood | N | 40 | |
GSE8970 | Leukemia | A two-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia | 2007 | Blood | N | 34 | |
GSE33290 | Leukemia | Gene expression signatures of dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib | 2011 | Blood | N | 28 | |
GSE42030 | Leukemia | Differential gene expression profile of newly diagnosed versus relapse acute promyelocytic leukemia | 2012 | Bone Marrow | N | 16 | |